In England, less than 10% of those diagnosed with lung cancer survive for 5 years ([@bib5]). Lung cancer patients of lower socioeconomic position (SEP) have poorer survival ([@bib24]). It has been suggested that socioeconomic differences in receipt of cancer treatment might at least partially contribute to survival inequalities ([@bib35]). There is some evidence that socioeconomic inequalities in lung cancer survival can be statistically explained by inequalities in treatment ([@bib12]; [@bib9]).

Socioeconomic inequalities in receipt of lung cancer surgery and chemotherapy, but not radiotherapy, were found in both universal (UHCS) and non-universal health-care systems, in a recent systematic review and meta-analysis ([@bib8]). These findings could not be explained by the type of health-care system or by socioeconomic inequalities in stage at diagnosis. However, not all of the studies included in the review reported details of stage and histology, both of which influence treatment type ([@bib8]), and very few took comorbidity into account. The review authors recommended that the reasons for socioeconomic inequalities in treatment should be more thoroughly investigated in studies including statistical control for comorbidity, stage and histology ([@bib8]).

Performance status (PS), a global measure of functional status and an important consideration for clinicians treating lung cancer ([@bib19]), is a factor that has not previously been well explored in studies examining socioeconomic inequalities in treatment. Although comorbidity and PS measure different things (the number of concurrent health conditions over a period of time before cancer diagnosis and general health status at the time of lung cancer diagnosis, respectively), both variables may be used as surrogate measures of suitability for treatment ([@bib15]). It is unclear how well comorbidity and PS capture fitness for treatment but, as the number of comorbidities varies by SEP for cancer patients ([@bib13]), this may help to explain inequalities in treatment.

Lung cancers are broadly classified into small cell (SCLC) and non-small cell (NSCLC) cancers, with NSCLC accounting for ∼80% of lung cancers. Non-small cell lung cancer can be further divided into squamous cell carcinoma, adenocarcinoma and large cell carcinoma subtypes ([@bib19]). Squamous cell carcinoma is strongly associated with smoking, as is SCLC ([@bib10]). Adenocarcinomas are a morphologically heterogeneous group and, although they are associated with smoking ([@bib29]), they are also found in those who have never smoked, particularly in women ([@bib10]). As SEP is associated with smoking and with histological subtype ([@bib29]), histological subtype may confound the relationship between SEP and treatment for lung cancer.

In this study, we linked Northern and Yorkshire Cancer Registry and Information Centre (NYCRIS), Hospital Episode Statistics (HES) and National Lung Cancer Audit (LUCADA) data sets in order to examine the factors that may help to explain socioeconomic inequalities in lung cancer treatment (surgery, chemotherapy and radiotherapy). The role of stage, histology (and, within this, histological subtype), PS and comorbidity in statistically explaining socioeconomic inequalities in lung cancer treatment was specifically explored.

Materials and Methods
=====================

Data sources
------------

The Northern and Yorkshire Cancer Registry is one of eight English regional cancer registries that collect a common minimum cancer data set ([@bib21]). Data on SEP, age, sex, histology, tumour, year of diagnosis, GP referral and details of receipt of treatment (surgery, chemotherapy and radiotherapy) were obtained from registry data. Comorbidity data were obtained from HES.

Incomplete recording of stage data is a major limitation of UK cancer registry data. However, stage data are collected by the LUCADA, a non-mandatory register of clinical information on patients diagnosed with lung cancer in the United Kingdom. The audit initially included only a subset of registry patients (66% nationally in 2006, increasing to 93% in 2010; [@bib18]).

Records were allocated a unique, randomly generated, key number, derived from the NHS number by NYCRIS. Data from the three data sources (NYCRIS cancer registry, HES and LUCADA data) were anonymised and supplied by NYCRIS. The HES and LUCADA data were then linked to the regional registry data using key numbers.

Variables of interest
---------------------

Socioeconomic position was measured using the agreed methodology for all English cancer registries, the rank of the income domain of the Index of Multiple Deprivation (IMD). This is an area-based measure of SEP ([@bib11]), grouped into quintiles, where Q5 is the most deprived and Q1 the least deprived. The England-wide distribution of IMD was used. This is periodically updated to allow inclusion of the most recent data. The income domain of IMD2010 was used for patients diagnosed between 2007 and 2010. For those diagnosed in 2006 the income domain of IMD2007 was used.

Age at diagnosis was categorised into four groups: age \<60, 60--69, 70--79 and 80+ years. Year of diagnosis was included to take into account changes in rates of treatment over time. GP referral was categorised as yes or no.

Lung cancer was categorised into the following eight histological subtypes: adenocarcinoma, large cell carcinoma, non-small cell carcinoma, squamous cell carcinoma, small cell carcinoma, other specified carcinoma, unspecified carcinoma ([@bib26]) and neoplasm. Lung cancer histology was classified as NSCLC, including adenocarcinoma, large cell carcinoma, non-small cell carcinoma and squamous cell carcinoma subtypes; SCLC; and other histology (including unspecified carcinoma, neoplasm and other specified carcinomas (including carcinoid tumours)), using ICD-0-3 morphology codes to categorise histological subtypes ([@bib34]). When examining NSCLC and SCLC separately, the unspecified carcinoma and neoplasm subtypes were excluded and the other specified carcinoma subtype was included as probable NSCLC ([@bib26]).

A weighted comorbidity score was calculated by NYCRIS using the Charlson comorbidity index (CCI; [@bib4]) using the number of in-patient HES admissions for 16 specified conditions (excluding metastatic cancer) in the 3--18 months before diagnosis. HES-linked comorbidity data were not available for patients diagnosed in 2009--2010 as, because of national problems in calculating the comorbidity score, there was a time lag in data availability. Comorbidity score was categorised as 0, 1--2, 3+, missing or unavailable.

Stage and PS data were obtained from LUCADA. Stage was assigned using the TNM staging system ([@bib30]) and categorised as I, II, III, IV or missing. Performance status at the time of lung cancer diagnosis was recorded on a scale of 0 (asymptomatic) to 4 (bedridden) using the Eastern Cooperative Group PS scale ([@bib19]) and categorised as 0, 1--2, 3--4 or missing.

Analysis
--------

Data for 29 385 patients with a primary diagnosis of lung cancer (ICD10 C33 and C34), diagnosed between 1 January 2006 and 31 December 2010, were obtained. Of these, 652 had tumour registration based on death-certification only and were excluded from analyses, leaving an eligible cohort of 28 733.

The distribution of stage, histological subtype, PS and comorbidity by SEP was examined using *χ*^2^ tests. The distribution of each variable in the subgroup that had stage recorded (*n*=7769) was compared with that in the full cohort using *χ*^2^ tests to determine the representativeness of the subgroup.

Univariable and multivariable logistic regressions were used to examine the likelihood of receipt of each of three treatments -- surgery, chemotherapy and radiotherapy, at any time after diagnosis -- by SEP, in the full cohort and the staged subgroup. Receipt of surgery was also examined for probable NSCLC-only patients (*n*=16 278). Recipients of chemotherapy and radiotherapy were examined separately in probable NSCLC (*n*=16 278) and SCLC (*n*=3495) populations. Age, sex, histology (or histological subtype), year of diagnosis, GP referral, comorbidity, PS and stage (where available) were controlled for in fully adjusted models. A forward stepwise approach was used to explore which variables were important in explaining socioeconomic inequalities in treatment. The *R*^2^ statistic was examined as a measure of model fit, to determine the amount (%) of variance in receipt of treatment explained by each model. Odds ratios (ORs) with 95% confidence intervals (CIs) for the likelihood of receipt of treatment in each SEP quintile compared with the least deprived were reported. A likelihood ratio test was performed to determine the overall significance of each categorical variable. Analysis was carried out in Stata v12.0 (StataCorp, College Station, TX, USA).

Results
=======

[Table 1](#tbl1){ref-type="table"} shows the demographic and clinical characteristics of the cohort. Of the 28 733 patients included in the full cohort analysis, 7769 (27%) had stage and 8885 (31%) had a PS score recorded in LUCADA, and 8475 (29%) had a comorbidity score ascertained from HES. There were significant differences between the full cohort and the staged subgroup in the distribution of age group, histology, comorbidity and receipt of treatment, but not SEP or sex. The staged subgroups were younger, had a higher proportion of NSCLC patients and a higher proportion receiving treatment. Significant differences in distribution of PS, number of comorbidities and histology, but not stage at diagnosis, were seen by SEP. A higher proportion of more deprived patients had poor PS, more comorbidity and a squamous cell histological subtype ([Supplementary Table 1](#sup1){ref-type="supplementary-material"}).

Surgery
-------

In the full cohort, the odds of receipt of surgery were significantly lower in the most compared to the least deprived group in the unadjusted analysis (OR=0.78, 95% CI 0.69--0.89) and in the fully adjusted multivariable analysis (OR=0.75, 95% CI 0.65--0.86). When histology was further broken down into histological subtypes then the SEP OR was attenuated (OR=0.82, 95% CI 0.71--0.96) ([Table 2](#tbl2){ref-type="table"}) and the amount of outcome variance explained by the model greatly increased (from *R*^2^=24.32% to 35.29%).

A similar result was seen for receipt of surgery in the most, compared with the least, deprived group in patients with probable NSCLC (OR=0.84, 95% CI 0.72--0.98; [Supplementary Table 2](#sup1){ref-type="supplementary-material"}), and in the subgroup that had stage recorded (OR=0.61, 95% CI 0.44--0.83; [Supplementary Table 3](#sup1){ref-type="supplementary-material"}).

Chemotherapy
------------

Socioeconomic position was associated with receipt of chemotherapy in the fully adjusted full cohort model (OR=0.61, 95% CI 0.55--0.68). The inclusion of histological subtype rather than histology only marginally attenuated the odds ratio (OR=0.64, 95% CI 0.58--0.72; [Table 3](#tbl3){ref-type="table"}).

In the subgroup of patients who had stage recorded, no statistically significant association between SEP and receipt of chemotherapy was found in the unadjusted analysis (OR=0.86, 95% CI 0.73--1; [Table 4](#tbl4){ref-type="table"}) but was seen in a multivariable analysis including age, sex, histological subtype, year of diagnosis, GP referral, CCI score and stage (OR=0.73, 95% CI 0.60 to 0.88). However, on the addition of PS to the model the OR was attenuated and this association was no longer significant (OR=0.88, 95% CI 0.72--1.08; [Table 4](#tbl4){ref-type="table"}). Including PS also increased the model fit (*R*^2^=28.04% without PS, 35.86% with).

When chemotherapy was examined separately in probable NSCLC and SCLC populations, socioeconomic inequalities in receipt of chemotherapy were found for NSCLC (OR=0.67, 95% CI 0.59--0.76; [Supplementary Table 4](#sup1){ref-type="supplementary-material"}) and SCLC (OR=0.57, 95% CI 0.43--0.75; [Supplementary Table 5](#sup1){ref-type="supplementary-material"}). For NSCLC patients, the likelihood of chemotherapy increased over time but this was not seen for SCLC.

Radiotherapy
------------

No association between SEP and receipt of radiotherapy was found in the full cohort in the fully adjusted model including histology (OR=1.03, CI 0.95--1.13) or histological subtype (OR=1.02, CI 0.93--1.11; [Table 5](#tbl5){ref-type="table"}). Similar results were found in the subgroup of patients who had stage recorded (OR=1.01, 95% CI 0.86--1.19). Different patterns of results were seen when receipt of radiotherapy was examined separately in probable NSCLC (OR=1.11, 95% CI 1--1.24) ([Supplementary Table 6](#sup1){ref-type="supplementary-material"}) and SCLC (OR=0.84, 95% CI 0.66--1.07; [Supplementary Table 7](#sup1){ref-type="supplementary-material"}) populations, but again were nonsignificant.

Discussion
==========

Principal findings
------------------

This is one of the first UK registry-based studies to include a wide range of confounders and potentially important explanatory factors including stage, histology, comorbidity and PS, in order to determine their influence on socioeconomic inequalities in lung cancer treatment. In this study, we found socioeconomic inequalities in the receipt of surgery and chemotherapy, but not radiotherapy, for lung cancer, in the full cohort analyses. Having taken all the above factors into account, socioeconomic inequalities in receipt of surgery persisted. However, socioeconomic inequalities in receipt of chemotherapy were not found in the staged subgroup on addition of PS to the stepwise model.

Socioeconomic differences in PS statistically accounted for much of the socioeconomic inequality in receipt of chemotherapy in the staged subgroup. Socioeconomic differences in histological subtype may partially account for some of the observed socioeconomic differences in receipt of surgery observed.

Strengths and limitations
-------------------------

The use of multiple data set linkage (NYCRIS cancer registrations, HES and LUCADA) allowed us to include a broader range of potential confounders than previous UK registry studies ([@bib12]; [@bib3]). Only two other UK studies (using early-year LUCADA audit data) have included PS in a multivariable analysis of receipt of lung cancer treatment ([@bib27], [@bib28]). We were able to include later years of LUCADA data (2009--2010), which are more complete.

The population-based approach and the completeness and validity of the cancer registry data are the strengths of this study, although there may be some under-reporting of chemotherapy and radiotherapy treatments within registry data sets ([@bib25]). We used data from the north of England that may limit the generalisability of the findings to other locations. The high level of missing data for some variables is also a major limitation. Multiple imputation was considered but is not recommended, where over 50% of values for a variable are missing ([@bib33]). To address the problem of missing data, we analysed complete-case data for the subset of patients who had stage recorded (the majority of whom also had PS recorded). As results from complete-case analyses can be biased ([@bib32]) we also analysed the full cohort and included missing categories for stage, PS and comorbidity, although this too can result in bias.

The validity of PS and CCI score as proxy measures of patients well-being is unclear. Performance status is a measure of patients acute functional status and need for care, assigned on a scale of 0--4 by the care team. Only moderate agreement in allocating PS score was found in an interobserver reliability study ([@bib31]). However, there was good agreement when allocating good (PS 0--2) compared with poor PS (PS 3--4), which were similar to the groupings we employed.

The Charlson comorbidity index is a validated instrument for measuring comorbidity ([@bib4]) over a longer period of time. However, it may underestimate comorbidity as patients who suffer from a relevant condition but are treated entirely in primary care score zero. It has also been suggested that it is a crude measure of comorbidity, as patients with mild and severe forms of a disease receive the same score ([@bib3]). This could be a problem for conditions such as chronic pulmonary obstructive disease, where the severity of the disease is likely to influence the likelihood of receiving surgery for lung cancer. However, the index only contains details of conditions that are serious enough to require in-patient care.

Interpretation of results and comparison with other studies
-----------------------------------------------------------

Socioeconomic inequalities in receipt of surgery may be partially explained by socioeconomic differences in histological subtype. We found a significant association between SEP and histological subtype, with a lower proportion of squamous cell and higher proportion of adenocarcinoma subtype (and higher rates of treatment in this latter subtype) in the least deprived compared with most deprived group. A previous UK lung cancer study found that adenocarcinoma was less clearly associated with deprivation than other histological subtypes, possibly as it is less strongly associated with smoking ([@bib2]), and smoking is strongly socioeconomically patterned. It may be that health factors relating to smoking, rather than histological subtype, help to determine receipt of surgery, and we cannot rule out uncontrolled confounding related to smoking status. It is likely that smokers have generally poorer health and, although we were able to include PS and CCI score in the analysis, these measures may not fully capture this.

In agreement with the results from our systematic review of socioeconomic inequalities in lung cancer treatment ([@bib8]), we found socioeconomic inequalities in receipt of surgery, and these remained after inclusion of stage, PS and comorbidity. In contrast, the only two other UK studies that included PS in a multivariable analysis of receipt of treatment, using national LUCADA data, found no association between SEP and receipt of surgery but did find an association with receipt of chemotherapy ([@bib27], [@bib28]). We also found that, when including PS, SEP remained associated with a lower likelihood of receipt of chemotherapy in the full cohort but that SEP was no longer associated with receipt of chemotherapy in the staged subgroup.

The first few years of LUCADA data included only a small subset of registry patients and there were significant differences in stage at diagnosis, histology and PS when comparing patients from hospital Trusts with high levels of missing data with those who had low levels ([@bib28]). The validity of the pre-2007 LUCADA data has also been queried due to the poor entry of staging data ([@bib16]). It may be that patients included in LUCADA in the early years of the audit are not representative of the full spectrum of patients diagnosed with lung cancer in England and this may explain the different pattern of results found using early audit data compared with studies using registry data. Concordance of recording of data on receipt of chemotherapy in LUCADA compared with registry data is reportedly poor, with 48% of patients with chemotherapy recorded in national registry data having no record of chemotherapy in LUCADA ([@bib25]); therefore, again this might account for some of the differences found.

Socioeconomic inequalities in receipt of radiotherapy were not found, although different patterns were seen for NSCLC compared with SCLC, when examined separately. It was not possible to distinguish between palliative and radical radiotherapy. Low-dose palliative radiotherapy is most commonly given, whereas fewer than 10% of patients receive high-dose radiotherapy with potentially curative intent. It is possible that differential effects by SEP might be seen if treatment-intent was examined, with more deprived SEP patients more likely to get palliative radiotherapy, and less deprived patients are likely to get curative radiotherapy. Potentially, these differential effects could effectively cancel each other out in statistical analyses and might help to explain why no overall association was found.

Implications for policy and practice
------------------------------------

In this study, a higher percentage of more deprived patients had a squamous cell subtype that is strongly associated with smoking, although we were unable to measure smoking status in this cohort. Surgery rates were also lower for this histological subtype. Non-smokers are less likely to develop lung cancer and if they do then it may be that they are more likely to have a histological subtype that is more amenable to surgery. This is a further reason, if any other were required, to continue to promote aggressive antismoking and smoking-cessation campaigns.

The guidelines indicate that chemotherapy should be offered to stage III NSCLC patients and to stage IV patients with good PS ([@bib19]). Socioeconomic differences in PS may determine whether a patient receives chemotherapy. Although there is a long chain of causality from health behaviours earlier in life to health status in later life, healthy behaviours should be encouraged, as patients who are in better health are likely to have a greater chance of receiving chemotherapy. It is unclear whether making lifestyle changes once diagnosed with cancer is likely to do much to improve PS, although a recent systematic review and meta-analysis produced preliminary evidence for improved survival for early-stage lung cancer patients who quit smoking after diagnosis ([@bib22]).

We were unable to take patient choice into account. Poorer health literacy may influence patient choice and understanding of risk, and this may vary by SEP ([@bib23]), as might more fatalistic attitudes and health beliefs. If patients have poor capacity to process and understand basic health information, then they are less able to make appropriate health and treatment decisions ([@bib20]). It is important that clinicians take this into account when discussing treatment options.

Differences in communication patterns between health professionals and patients by SEP have been described that may influence the treatment prescribed ([@bib17]). Doctors may make treatment decisions based on which patients they consider likely to do well, using factors such as age, weight and comorbidity ([@bib6]) and these judgements may disadvantage more deprived lung cancer patients ([@bib7]). Treatment decisions should be clearly documented and should be based on the clinical guidelines.

Further research
----------------

The results from this study suggest that socioeconomic inequalities in PS statistically explain socioeconomic inequalities in receipt of chemotherapy in the subgroup of patients whose cancer was staged. However, this staged subgroup may not be representative of the full regional cohort as patients within this were more likely to be younger and to receive treatment. A previous study has shown a socioeconomic gradient in completeness of data on stage and grade of cancer, which could be interpreted as inequality in investigative intensiveness ([@bib1]). It may be that younger patients receive more intensive investigation and so are more likely to be staged ([@bib1]) and so, although PS may explain inequalities in chemotherapy in this group, they are a selective cohort. This is a relationship that needs to be clarified in other data sets, ideally with lower levels of missing data for stage and PS.

The observed relationship between histological subtype and receipt of surgery has not been consistently reported ([@bib14]) and further studies are also needed to confirm this association.

It would be useful to look at receipt of radiotherapy by curative or palliative intent to determine whether there are different patterns in likelihood of treatment by SEP.

Conclusions
===========

Socioeconomic inequalities in lung cancer surgery and chemotherapy, but not in radiotherapy, were found. We have been able to investigate a number of factors that may be important in the relationship between SEP and receipt of treatment that have previously not been well explored; however, the high levels of missing data limit the conclusions that can be drawn.

Although histological subtype may account for some of the socioeconomic gradients in surgery, it does not explain it all. Socioeconomic inequalities in PS did not explain inequalities in chemotherapy in the full cohort analyses (although it did within the staged subgroup), and nor did stage or number of comorbidities, suggesting that other factors are responsible.

Further research is required to investigate the unexplained variance in treatment rates, exploring factors such as patient choice, doctor--patient communication of risk and benefit, and possible system variation by region, hospital and individual clinician.
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###### 

Click here for additional data file.

###### Demographic and clinical characteristics of full cohort and staged subgroup

                            **Full cohort**   **Staged subgroup**                            
  ------------------------- ----------------- --------------------- ------ ------ ---------- ---------
  Deprivation quintile      28 733            100                   7769   100    0.86       0.930
  1 (Least deprived)        3389              11.8                  931    12.0               
  2                         4178              14.5                  1118   14.4               
  3                         4848              16.9                  1300   16.7               
  4                         6710              23.4                  1831   23.6               
  5 (Most deprived)         608               33.4                  2589   33.3               
  Sex                       28 733            100                   7769   100    0.44       0.511
  Female                    13 254            46.1                  3559   45.8               
  Male                      15 479            53.9                  4210   54.2               
  Age group                 28 733            100                   7769   100    62.65      \<0.001
  \<60                      3682              12.8                  1041   13.4               
  60--69                    7595              26.4                  2189   28.2               
  70--79                    10 248            35.7                  2843   36.6               
  80+                       7208              25.1                  1696   21.8               
  Year of diagnosis         28 733            100                   7769   100    2.1e+0.3   \<0.001
  2006                      5533              19.3                  671    8.6                
  2007                      5712              19.9                  866    11.2               
  2008                      5851              20.4                  1556   20.0               
  2009                      5871              20.4                  2140   27.6               
  2010                      5766              20.1                  2536   32.6               
  Comorbidity score         28 733            100                   7769   100    39.02      \<0.001
  0                         4010              14.0                  995    12.8               
  1--2                      3531              12.3                  857    11.0               
  3+                        934               3.3                   226    2.9                
  Missing                   10 175            35.4                  1977   25.5               
  Unavailable               10 083            35.1                  3714   47.8               
  Stage                     28 733            100                   7769   100    2.9e+0.4   \<0.001
  I                         1186              4.1                   1186   15.3               
  II                        552               1.9                   552    7.1                
  III                       2273              7.9                   2273   29.3               
  IV                        3758              13.1                  3758   48.4               
  Missing                   20 964            73.0                  ---    ---                
  Performance status        28 733            100                   7769   100    1.8e+0.4   \<0.001
  0                         1842              6.4                   1493   19.2               
  1--2                      4865              16.9                  3870   49.8               
  3--4                      2178              7.6                   1763   22.7               
  Missing                   19 848            69.1                  643    8.3                
  GP referral               28 733            100                   7769   100    976.52     \<0.001
  Yes                       15 452            53.8                  5351   68.9               
  No                        13 281            46.2                  2418   31.1               
  Histology                 28 733            100                   7769   100    765.53     \<0.001
  NSCLC                     15 123            52.6                  5116   65.9               
  SCLC                      3495              12.2                  582    7.5                
  Other                     10 115            35.2                  2071   26.7               
  Histological subtype      28 733            100                   7769   100    849.92     \<0.001
  Adenocarcinoma            4462              15.5                  1473   19.0               
  Squamous cell             5229              18.2                  1850   23.8               
  Large cell                768               2.7                   169    2.2                
  Non-small cell            4664              16.2                  1624   20.9               
  Small cell                3495              12.2                  582    7.5                
  Other specified           1155              4.0                   298    3.8                
  Unspecified carcinoma     520               1.8                   93     1.2                
  Neoplasm                  8440              29.4                  1680   21.6               
  Receipt of surgery        28 733            100                   7769   100    92.99      \<0.001
  Yes                       2894              10.1                  1001   12.9               
  No                        25 839            89.9                  6768   87.1               
  Receipt of chemotherapy   28 733            100                   7769   100    192.96     \<0.001
  Yes                       8348              29.1                  2732   35.2               
  No                        20 385            70.9                  5037   64.8               
  Receipt of radiotherapy   28 733            100                   7769   100    175.30     \<0.001
  Yes                       9611              33.4                  3069   39.5               
  No                        19 122            66.6                  4700   60.5               

Abbreviations: CCI score=Charlson comorbidity score; CI=confidence interval; IMD=Index of Multiple Deprivation; NSCLC=non-small cell lung cancer; OR=odds ratio; SCLC=small cell lung cancer.

*χ*^2^=*χ*^2^ for difference in variable distribution between full cohort and staged subgroup.

###### Likelihood of receipt of lung cancer surgery, by SEP, adjusted for selected patient, tumour and system factors, for full cohort

                          **Receipt of surgery (2894/28 733)**   **Unadjusted (*****n*****=28 733)**    **Adjusted -- sex, age, year, CCI, GP referral, stage, PS, histological subtype (*****n*****=28 733,** ***R***^**2**^**=35.29%)**                                               
  ----------------------- -------------------------------------- ------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ------ ------ --------- ------ ------ ------ ---------
  Deprivation quintile    2894                                   10.1                                                                                                                                                                                    \<0.001                        0.01
  1 (Least deprived)      400                                    11.8                                                                                                                                                                                               1.00                 
  2                       458                                    11.0                                                                                                 0.92                                                                  0.80   1.06             0.91   0.77   1.08   
  3                       512                                    10.6                                                                                                 0.88                                                                  0.77   1.01             0.97   0.82   1.15   
  4                       613                                    9.1                                                                                                  0.75                                                                  0.66   0.86             0.80   0.68   0.94   
  5 (Most deprived)       911                                    9.5                                                                                                  0.78                                                                  0.69   0.89             0.82   0.71   0.96   
  Sex                     2894                                   10.1                                                                                                                                                                                                                   \<0.001
  Female                  1405                                   10.6                                                                                                                                                                                               1.00                 
  Male                    1489                                   9.6                                                                                                                                                                                                0.78   0.71   0.85   
  Age group               2894                                   10.1                                                                                                                                                                                                                   \<0.001
  \<60                    560                                    15.2                                                                                                                                                                                               1.00                 
  60--69                  1118                                   14.7                                                                                                                                                                                               1.04   0.92   1.19   
  70--79                  1048                                   10.2                                                                                                                                                                                               0.79   0.69   0.90   
  80+                     168                                    2.3                                                                                                                                                                                                0.22   0.18   0.26   
  Year of diagnosis       2894                                   10.1                                                                                                                                                                                                                   \<0.001
  2006                    505                                    9.1                                                                                                                                                                                                1.00                 
  2007                    547                                    9.6                                                                                                                                                                                                1.10   0.95   1.27   
  2008                    502                                    8.6                                                                                                                                                                                                0.96   0.83   1.12   
  2009                    682                                    11.6                                                                                                                                                                                               1.50   1.31   1.88   
  2010                    658                                    11.4                                                                                                                                                                                               1.58   1.29   1.92   
  CCI score               2894                                   10.1                                                                                                                                                                                                                   0.0002
  0                       482                                    12.0                                                                                                                                                                                               1.00                 
  1--2                    326                                    9.2                                                                                                                                                                                                0.90   0.75   1.07   
  3+                      83                                     9.0                                                                                                                                                                                                1.01   0.75   1.36   
  Missing                 1021                                   10.0                                                                                                                                                                                               0.91   0.79   1.06   
  Unavailable             982                                    9.7                                                                                                                                                                                                0.69   0.58   0.81   
  GP referral             2894                                   10.1                                                                                                                                                                                                                   \<0.001
  No                      979                                    7.4                                                                                                                                                                                                1.00                 
  Yes                     1915                                   12.4                                                                                                                                                                                               1.27   1.15   1.40   
  Stage                   2894                                   10.1                                                                                                                                                                                                                   \<0.001
  I                       607                                    51.2                                                                                                                                                                                               1.00                 
  II                      195                                    35.3                                                                                                                                                                                               0.43   0.33   0.56   
  III                     144                                    6.3                                                                                                                                                                                                0.04   0.04   0.06   
  IV                      55                                     1.5                                                                                                                                                                                                0.01   0.01   0.02   
  Missing                 1893                                   9.0                                                                                                                                                                                                0.11   0.09   0.14   
  Performance status      2894                                   10.1                                                                                                                                                                                                                   \<0.001
  0                       583                                    31.7                                                                                                                                                                                               1.00                 
  1--2                    480                                    9.9                                                                                                                                                                                                0.33   0.27   0.40   
  3--4                    15                                     0.7                                                                                                                                                                                                0.05   0.03   0.09   
  Missing                 1816                                   9.2                                                                                                                                                                                                0.41   0.34   0.50   
  Histological subtype    2894                                   10.1                                                                                                                                                                                                                   \<0.001
  Adenocarcinoma          998                                    22.4                                                                                                                                                                                               1.00                 
  Squamous cell           1011                                   19.3                                                                                                                                                                                               0.86   0.77   0.97   
  Large cell              124                                    16.2                                                                                                                                                                                               0.64   0.51   0.80   
  Non-small cell          215                                    4.6                                                                                                                                                                                                0.19   0.16   0.22   
  Other (specified)       470                                    40.7                                                                                                                                                                                               2.40   2.06   2.80   
  Small cell              54                                     1.6                                                                                                                                                                                                0.06   0.04   0.07   
  Unspecified carcinoma   14                                     2.7                                                                                                                                                                                                0.14   0.08   0.25   
  Neoplasm                8                                      0.1                                                                                                                                                                                                0.01   0.00   0.01   

Abbreviations: CCI score=Charlson comorbidity score; CI=confidence interval; IMD=Index of Multiple Deprivation; NSCLC=non-small cell lung cancer; OR=odds ratio; PS=performance status; SCLC=small cell lung cancer; SEP=socioeconomic position.

###### Likelihood of receipt of lung cancer chemotherapy, by SEP, adjusted for selected patient, tumour and system factors, for full cohort

                          **Receiving chemotherapy (8348/28 733)**   **Unadjusted (*****n*****=28 733)**    **Adjusted -- sex, age, year, comorbidity score, GP referral, stage, PS, histological subtype (*****n*****=28 733,** ***R***^**2**^**=34.97%)**                                               
  ----------------------- ------------------------------------------ ------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------- ------ ------ --------- ------ ------ ------ ---------
  Deprivation quintile    8348                                       29.1                                                                                                                                                                                                  \<0.001                        \<0.001
  1 (least deprived)      1133                                       33.4                                                                                                        1.00                                                                                                 1.00                 
  2                       1275                                       30.5                                                                                                        0.87                                                                         0.79   0.96             0.85   0.75   0.96   
  3                       1425                                       29.4                                                                                                        0.83                                                                         0.75   0.91             0.82   0.73   0.93   
  4                       1898                                       28.3                                                                                                        0.79                                                                         0.72   0.86             0.70   0.63   0.79   
  5 (Most deprived)       2617                                       27.2                                                                                                        0.75                                                                         0.69   0.81             0.64   0.58   0.72   
  Sex                     8348                                       29.1                                                                                                                                                                                                                                 0.43
  Female                  3810                                       28.8                                                                                                                                                                                                             1.00                 
  Male                    4538                                       29.3                                                                                                                                                                                                             1.03   0.96   1.10   
  Age group               8348                                       29.1                                                                                                                                                                                                                                 \<0.001
  \<60                    2221                                       60.3                                                                                                                                                                                                             1.00                 
  60--69                  3332                                       43.9                                                                                                                                                                                                             0.54   0.49   0.60   
  70--79                  2452                                       23.9                                                                                                                                                                                                             0.24   0.22   0.27   
  80+                     343                                        4.8                                                                                                                                                                                                              0.05   0.05   0.06   
  Year of diagnosis       8348                                       29.1                                                                                                                                                                                                                                 \<0.001
  2006                    1506                                       27.2                                                                                                                                                                                                             1.00                 
  2007                    1667                                       29.2                                                                                                                                                                                                             1.19   1.07   1.31   
  2008                    1681                                       28.7                                                                                                                                                                                                             1.09   0.98   1.20   
  2009                    1773                                       30.2                                                                                                                                                                                                             1.47   1.28   1.68   
  2010                    1721                                       29.9                                                                                                                                                                                                             1.49   1.29   1.72   
  Comorbidity score       8348                                       29.1                                                                                                                                                                                                                                 \<0.001
  0                       1224                                       30.5                                                                                                                                                                                                             1.00                 
  1--2                    669                                        19.0                                                                                                                                                                                                             0.67   0.59   0.77   
  3+                      122                                        13.1                                                                                                                                                                                                             0.50   0.39   0.63   
  Missing                 3503                                       34.4                                                                                                                                                                                                             1.12   1.00   1.24   
  Unavailable             2830                                       28.1                                                                                                                                                                                                             0.76   0.67   0.85   
  GP referral             8348                                       29.1                                                                                                                                                                                                                                 \<0.001
  No                      2566                                       19.3                                                                                                                                                                                                             1.00                 
  Yes                     5782                                       37.4                                                                                                                                                                                                             2.04   1.91   2.19   
  Stage                   8348                                       29.1                                                                                                                                                                                                                                 \<0.001
  I                       223                                        18.8                                                                                                                                                                                                             1.00                 
  II                      163                                        29.5                                                                                                                                                                                                             2.17   1.65   2.85   
  III                     1032                                       45.4                                                                                                                                                                                                             5.77   4.71   7.06   
  IV                      1314                                       35.0                                                                                                                                                                                                             4.49   3.69   5.46   
  Missing                 5616                                       26.8                                                                                                                                                                                                             3.55   2.90   4.34   
  Performance status      8348                                       29.1                                                                                                                                                                                                                                 \<0.001
  0                       1151                                       62.5                                                                                                                                                                                                             1.00                 
  1--2                    2067                                       42.5                                                                                                                                                                                                             0.49   0.43   0.56   
  3--4                    113                                        5.2                                                                                                                                                                                                              0.04   0.03   0.05   
  Missing                 5017                                       25.3                                                                                                                                                                                                             0.32   0.27   0.37   
  Histological subtype    8348                                       29.1                                                                                                                                                                                                                                 \<0.001
  Adenocarcinoma          1658                                       37.2                                                                                                                                                                                                             1.00                 
  Squamous cell           1767                                       33.8                                                                                                                                                                                                             0.89   0.81   0.98   
  Large cell              271                                        35.3                                                                                                                                                                                                             0.94   0.79   1.12   
  Non-small cell          1670                                       35.8                                                                                                                                                                                                             0.97   0.88   1.07   
  Other (specified)       377                                        32.6                                                                                                                                                                                                             0.84   0.72   0.98   
  Small cell              2381                                       68.1                                                                                                                                                                                                             5.25   4.70   5.86   
  Unspecified carcinoma   66                                         12.7                                                                                                                                                                                                             0.36   0.27   0.49   
  Neoplasm                158                                        1.9                                                                                                                                                                                                              0.08   0.06   0.09   

Abbreviations: CCI score=Charlson comorbidity score; CI=confidence interval; IMD=Index of Multiple Deprivation; NSCLC=non-small cell lung cancer; OR=odds ratio; PS=performance status; SCLC=small cell lung cancer; SEP=socioeconomic position.

###### Likelihood of receipt of lung cancer chemotherapy, by SEP, adjusted for selected patient, tumour and system factors, for staged subgroup

                          **Receiving chemotherapy (2732/7769)**   **Unadjusted (*****n*****=7769)**    **Adjusted -- sex, age, year, CCI, GP referral, stage, PS, histological subtype (*****n*****=7769,** ***R***^**2**^**=35.86%)**                                            
  ----------------------- ---------------------------------------- ----------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ---------
  Deprivation quintile    2732                                     35.2                                                                                                                                                                                0.19                        0.34
  1 (Least deprived)      351                                      37.7                                                                                              1.00                                                                                      1.00                 
  2                       414                                      37.0                                                                                              0.97                                                                 0.81   1.16          1.00   0.80   1.26   
  3                       445                                      34.2                                                                                              0.86                                                                 0.72   1.02          1.04   0.83   1.31   
  4                       638                                      34.8                                                                                              0.88                                                                 0.75   1.04          0.92   0.74   1.14   
  5 (Most deprived)       884                                      34.1                                                                                              0.86                                                                 0.73   1.00          0.88   0.72   1.08   
  Sex                     2732                                     35.2                                                                                                                                                                                                            0.78
  Female                  1255                                     35.3                                                                                                                                                                                        1.00                 
  Male                    1477                                     35.1                                                                                                                                                                                        1.02   0.90   1.15   
  Age group               2732                                     35.2                                                                                                                                                                                                            \<0.001
  \<60                    690                                      66.3                                                                                                                                                                                        1.00                 
  60--69                  1103                                     50.4                                                                                                                                                                                        0.57   0.48   0.69   
  70--79                  821                                      28.9                                                                                                                                                                                        0.27   0.22   0.32   
  80+                     118                                      7.0                                                                                                                                                                                         0.06   0.05   0.08   
  Year of diagnosis       2732                                     35.2                                                                                                                                                                                                            0.03
  2006                    211                                      31.5                                                                                                                                                                                        1.00                 
  2007                    323                                      37.3                                                                                                                                                                                        1.48   1.13   1.93   
  2008                    556                                      35.7                                                                                                                                                                                        1.39   1.09   1.77   
  2009                    758                                      35.4                                                                                                                                                                                        1.46   1.09   1.95   
  2010                    884                                      34.9                                                                                                                                                                                        1.46   1.08   1.97   
  CCI score               2732                                     35.2                                                                                                                                                                                                            0.03
  0                       353                                      35.5                                                                                                                                                                                        1.00                 
  1--2                    203                                      23.7                                                                                                                                                                                        0.74   0.57   0.95   
  3+                      40                                       17.7                                                                                                                                                                                        0.68   0.43   1.07   
  Missing                 800                                      40.5                                                                                                                                                                                        1.05   0.84   1.33   
  Unavailable             1336                                     36.0                                                                                                                                                                                        0.92   0.74   1.15   
  GP referral             2732                                     35.2                                                                                                                                                                                                            \<0.001
  No                      603                                      24.9                                                                                                                                                                                        1.00                 
  Yes                     2129                                     39.8                                                                                                                                                                                        1.98   1.72   2.28   
  Stage                   2732                                     35.2                                                                                                                                                                                                            \<0.001
  I                       223                                      18.8                                                                                                                                                                                        1.00                 
  II                      163                                      29.5                                                                                                                                                                                        2.26   1.71   2.98   
  III                     1032                                     45.4                                                                                                                                                                                        6.06   4.92   7.46   
  IV                      1314                                     35.0                                                                                                                                                                                        4.70   3.84   5.75   
  Performance status      2732                                     35.2                                                                                                                                                                                                            \<0.001
  0                       933                                      62.5                                                                                                                                                                                        1.00                 
  1--2                    1561                                     40.3                                                                                                                                                                                        0.41   0.35   0.48   
  3--4                    78                                       4.4                                                                                                                                                                                         0.03   0.02   0.04   
  Missing                 160                                      24.9                                                                                                                                                                                        0.27   0.21   0.34   
  Histological subtype    2732                                     35.2                                                                                                                                                                                                            \<0.001
  Adenocarcinoma          652                                      44.3                                                                                                                                                                                        1.00                 
  Squamous cell           732                                      39.6                                                                                                                                                                                        0.81   0.68   0.96   
  Large cell              73                                       43.2                                                                                                                                                                                        0.96   0.65   1.41   
  Non-small cell          683                                      42.1                                                                                                                                                                                        0.91   0.77   1.09   
  Other (specified)       110                                      36.9                                                                                                                                                                                        0.85   0.63   1.16   
  Small cell              411                                      70.6                                                                                                                                                                                        5.42   4.15   7.07   
  Unspecified carcinoma   19                                       20.4                                                                                                                                                                                        0.45   0.24   0.84   
  Neoplasm                52                                       3.1                                                                                                                                                                                         0.10   0.08   0.14   

Abbreviations: CCI score=Charlson comorbidity score; CI=confidence interval; IMD=Index of Multiple Deprivation; NSCLC=non-small cell lung cancer; OR=odds ratio; PS=performance status; SCLC=small cell lung cancer; SEP=socioeconomic position.

###### Likelihood of receipt of lung cancer radiotherapy, by SEP, adjusted for selected patient, tumour and system factors, for full cohort

                          **Receiving radiotherapy (9611/28 733)**   **Unadjusted (*****n*****=28 733)**    **Adjusted -- sex, age, year, CCI, GP referral, stage, PS, histological subtype (*****n*****=28 733,** ***R***^**2**^**=12.20%)**                                            
  ----------------------- ------------------------------------------ ------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ---------
  Deprivation quintile    9611                                       33.5                                                                                                                                                                                    0.80                        0.70
  1 (Least deprived)      1126                                       33.2                                                                                                 1.00                                                                                       1.00                 
  2                       1401                                       33.5                                                                                                 1.01                                                                  0.92   1.12          1.04   0.94   1.15   
  3                       1612                                       33.3                                                                                                 1.00                                                                  0.91   1.10          1.02   0.92   1.13   
  4                       2215                                       33.0                                                                                                 0.99                                                                  0.91   1.08          0.98   0.89   1.08   
  5 (Most deprived)       3257                                       33.9                                                                                                 1.03                                                                  0.95   1.12          1.02   0.93   1.11   
  Sex                     9611                                       33.5                                                                                                                                                                                                                0.38
  Female                  4258                                       32.1                                                                                                                                                                                            1.00                 
  Male                    5353                                       34.6                                                                                                                                                                                            1.02   0.97   1.08   
  Age group               9611                                       33.5                                                                                                                                                                                                                \<0.001
  \<60                    1707                                       46.4                                                                                                                                                                                            1.00                 
  60--69                  3140                                       41.3                                                                                                                                                                                            0.85   0.78   0.92   
  70--79                  3330                                       32.5                                                                                                                                                                                            0.66   0.61   0.72   
  80+                     1434                                       19.9                                                                                                                                                                                            0.50   0.45   0.55   
  Year of diagnosis       9611                                       33.5                                                                                                                                                                                                                \<0.001
  2006                    1857                                       33.6                                                                                                                                                                                            1.00                 
  2007                    1865                                       32.7                                                                                                                                                                                            0.95   0.88   1.04   
  2008                    1865                                       31.9                                                                                                                                                                                            0.89   0.81   0.97   
  2009                    2060                                       35.1                                                                                                                                                                                            1.11   1.00   1.23   
  2010                    1964                                       34.1                                                                                                                                                                                            1.11   1.00   1.25   
  Comorbidity score       9611                                       33.5                                                                                                                                                                                                                0.004
  0                       1422                                       35.5                                                                                                                                                                                            1.00                 
  1--2                    1042                                       29.5                                                                                                                                                                                            0.92   0.83   1.02   
  3+                      228                                        24.4                                                                                                                                                                                            0.79   0.66   0.94   
  Missing                 3657                                       35.9                                                                                                                                                                                            0.96   0.88   1.05   
  Unavailable             3262                                       32.4                                                                                                                                                                                            0.85   0.77   0.93   
  GP referral             9611                                       33.5                                                                                                                                                                                                                \<0.001
  No                      3262                                       24.6                                                                                                                                                                                            1.00                 
  Yes                     6349                                       41.1                                                                                                                                                                                            1.66   1.57   1.75   
  Stage                   9611                                       33.5                                                                                                                                                                                                                \<0.001
  I                       370                                        31.2                                                                                                                                                                                            1.00                 
  II                      234                                        42.4                                                                                                                                                                                            1.44   1.16   1.80   
  III                     1206                                       53.1                                                                                                                                                                                            2.24   1.91   2.63   
  IV                      1259                                       33.5                                                                                                                                                                                            1.17   1.00   1.36   
  missing                 6542                                       31.2                                                                                                                                                                                            1.45   1.24   1.69   
  Performance status      9611                                       33.5                                                                                                                                                                                                                \<0.001
  0                       832                                        45.2                                                                                                                                                                                            1.00                 
  1--2                    2375                                       48.8                                                                                                                                                                                            1.39   1.24   1.56   
  3--4                    387                                        17.8                                                                                                                                                                                            0.52   0.44   0.61   
  Missing                 6017                                       30.3                                                                                                                                                                                            0.88   0.77   1.00   
  Histological subtype    9611                                       33.5                                                                                                                                                                                                                \<0.001
  Adenocarcinoma          1508                                       33.8                                                                                                                                                                                            1.00                 
  Squamous cell           2509                                       48.0                                                                                                                                                                                            1.73   1.59   1.89   
  Large cell              326                                        42.5                                                                                                                                                                                            1.45   1.24   1.70   
  Non-small cell          2269                                       48.7                                                                                                                                                                                            1.88   1.72   2.05   
  Other (specified)       267                                        23.1                                                                                                                                                                                            0.59   0.51   0.69   
  Small cell              1562                                       44.7                                                                                                                                                                                            1.59   1.44   1.75   
  Unspecified carcinoma   163                                        31.4                                                                                                                                                                                            1.14   0.93   1.40   
  Neoplasm                1007                                       11.9                                                                                                                                                                                            0.39   0.35   0.43   

Abbreviations: CCI score=Charlson comorbidity score; CI=confidence interval; IMD=Index of Multiple Deprivation; NSCLC=non-small cell lung cancer; OR=odds ratio; PS=performance status; SCLC=small cell lung cancer; SEP=socioeconomic position.
